With the subgroup characterized by non-general obesity and metabolically healthy status as a reference, the ALT levels of the other five subgroups were significantly increased (all P < 0.05), with the subgroup characterized by general obesity and metabolically unhealthiness having the greatest effect. The gene discussed is GPT; the disease is obesity disorder.